The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Going for a regular eye check-up is about more than assessing your ability to see. Your eyes can be a window to early ...

In China, doctors reported a case of short-term vision loss in a 24-year-old resident of Zhangjiajie. According to doctors, the cause was changes in the fundus, characteristic of an extremely high ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Diabetic eye damage can begin early, even before diagnosis, silently threatening vision. Early screenings and lifestyle ...

Your eyes can tell you a lot about your health. They can show signs of underlying issues like thyroid problems, liver disease, diabetes, and more.

The week-long awareness campaign began with a creative colouring competition for young patients visiting the paediatric ophthalmology OPD, followed by extensive parent engagement through pamphlet dist ...

Corza Medical, a global medical technology company, today announced that its Ophthalmology business unit has launched the SensorTek™ ROP Kit, the first ...

Corza Medical , a global medical technology company, today announced that its Ophthalmology business unit has launched the SensorTek™ ROP Kit, the first and only single-use kit on the market that ...

A recent study published in the Journal of Cataract & Refractive Surgery found that Yttrium Aluminum Garnet (YAG) laser ...